Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients
, , , , , , , , , und
20. Nov. 2019
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 20. Nov. 2019
Seitenbereich: 488 - 496
Eingereicht: 31. Juli 2019
Akzeptiert: 04. Okt. 2019
DOI: https://doi.org/10.2478/raon-2019-0055
Schlüsselwörter
© 2019 Marin Prpic, Ivan Kruljac, Davor Kust, Petar Suton, Neva Purgar, Lora Kirigin Bilos, Marin Gregov, Iva Mrcela, Maja Franceschi, Nikola Djakovic, Ana Frobe, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1

Figure 2

Figure 3

General characteristics of the study population; continuous variables are presented as mean ± SD and categorical ones as N (%)
Euthyroidism | Hypothyroidism | P | |||
---|---|---|---|---|---|
Age | 60.2 | ± 10.0 | 59.3 | ± 9.5 | 0.556 |
Male gender | 79 | (91.9) | 58 | (82.9) | 0.087 |
Primary tumor | 0.851 | ||||
Unknown primary(C80) | 5 | (5.8) | 2 | (2.9) | |
Hypopharinx | 16 | (18.6) | 12 | (17.1) | |
Larynx | 18 | (20.9) | 16 | (22.9) | |
Nasopharynx | 3 | (3.5) | 5 | (7.1) | |
Oral cavity | 11 | (12.8) | 9 | (12.9) | |
Oropharynx | 28 | (32.6) | 24 | (34.3) | |
Other | 5 | (5.8) | 2 | (2.9) | |
T status | 0.106 | ||||
1 | 10 | (11.6) | 14 | (20.0) | |
2 | 35 | (40.7) | 22 | (31.4) | |
3 | 16 | (18.6) | 21 | (30.0) | |
4 | 17 | (19.8) | 11 | (15.7) | |
x | 8 | (9.3) | 2 | (2.9) | |
N status | 0.508 | ||||
N0 | 28 | (32.6) | 16 | (22.9) | |
N1 | 16 | (18.6) | 10 | (14.3) | |
N2a | 1 | (1.2) | 3 | (4.3) | |
N2b | 25 | (29.1) | 23 | (32.9) | |
N2c | 12 | (14.0) | 13 | (18.6) | |
N3 | 4 | (4.7) | 5 | (7.1) | |
Neck metastases present | 58 | (67.4) | 54 | (77.1) | 0.181 |
Chemotherapy | 43 | (50.0) | 43 | (61.4) | 0.153 |
Surgery involving thyroid | 0.758 | ||||
None | 18 | (20.9) | 14 | (20.0) | |
Lobectomy | 10 | (11.6) | 11 | (15.7) | |
Non-thyroid | 58 | (67.4) | 45 | (64.3) |
Dosimetric characteristics of the study population; continuous variables are presented as mean ± SD and categorical ones as n (%)
Euthyroidism | Hypothyroidism | P | |||
---|---|---|---|---|---|
Dmin | 4178 | ± 1652 | 5005 | ± 869 | <0.001 |
Dmax | 6298 | ± 704 | 6304 | ± 587 | 0.867 |
Dmean | 5487 | ± 1055 | 5836 | ± 537 | 0.087 |
D02 | 6172 | ± 650 | 6222 | ± 582 | 0.765 |
D10 | 6041 | ± 663 | 6133 | ± 577 | 0.410 |
D20 | 5953 | ± 709 | 6062 | ± 567 | 0.373 |
D30 | 5818 | ± 884 | 5992 | ± 560 | 0.242 |
D40 | 5697 | ± 1003 | 5927 | ± 550 | 0.238 |
D50 | 5503 | ± 1168 | 5869 | ± 537 | 0.094 |
D60 | 5314 | ± 1414 | 5775 | ± 583 | 0.093 |
D70 | 5181 | ± 1495 | 5704 | ± 607 | 0.042 |
D80 | 5063 | ± 1540 | 5616 | ± 622 | 0.032 |
D90 | 4903 | ± 1595 | 5520 | ± 637 | 0.019 |
D98 | 4640 | ± 1663 | 5322 | ± 681 | 0.006 |
Total thyroid volume | 15.951 | ± 8.399 | 11.461 | ± 4.513 | <0.001 |
V10 | 96.85 | ± 11.27 | 100.00 | ± 0.00 | 0.005 |
V20 | 95.38 | ± 14.80 | 100.00 | ± 0.00 | 0.002 |
V30 | 94.40 | ± 16.57 | 99.64 | ± 2.99 | 0.005 |
V40 | 93.44 | ± 18.36 | 99.34 | ± 5.14 | 0.019 |
V45 | 92.70 | ± 19.66 | 98.99 | ± 5.51 | 0.040 |
V50 | 85.99 | ± 24.35 | 95.29 | ± 9.95 | 0.003 |
V55 | 53.15 | ± 41.84 | 65.72 | ± 40.89 | 0.053 |
V60 | 40.56 | ± 37.74 | 49.27 | ± 37.49 | 0.163 |
V65 | 12.82 | ± 25.13 | 13.61 | ± 26.67 | 0.888 |
V70 | 4.38 | ± 15.45 | 1.81 | ± 9.25 | 0.193 |
VS10 | 0.59 | ± 2.10 | 0.00 | ± 0.00 | 0.009 |
VS20 | 0.87 | ± 2.82 | 0.00 | ± 0.00 | 0.002 |
VS30 | 1.02 | ± 3.07 | 0.04 | ± 0.36 | 0.008 |
VS40 | 1.23 | ± 3.47 | 0.09 | ± 0.72 | 0.003 |
VS45 | 1.37 | ± 3.78 | 0.15 | ± 0.77 | 0.040 |
VS50 | 2.56 | ± 4.78 | 0.63 | ± 1.45 | 0.003 |
VS55 | 7.75 | ± 7.87 | 3.93 | ± 5.18 | 0.003 |
VS60 | 9.86 | ± 7.79 | 5.84 | ± 5.16 | 0.001 |
VS65 | 14.18 | ± 8.15 | 9.70 | ± 4.88 | <0.001 |
VS70 | 15.32 | ± 8.00 | 11.23 | ± 4.62 | <0.001 |
Area under the curve for each variable in predicting hypothyroidism
Variable(s) | AUC | SE | P | 95% Confidence Interval | |
---|---|---|---|---|---|
Lower Bound | Upper Bound | ||||
Dmin | .673 | .043 | .000 | .589 | .757 |
Dmax | .508 | .046 | .867 | .417 | .599 |
Dmean | .580 | .046 | .087 | .490 | .669 |
D02 | .514 | .046 | .765 | .423 | .605 |
D10 | .538 | .046 | .410 | .448 | .629 |
D20 | .542 | .046 | .373 | .451 | .632 |
D30 | .555 | .046 | .242 | .464 | .645 |
D40 | .555 | .046 | .238 | .465 | .645 |
D50 | .578 | .046 | .094 | .489 | .668 |
D60 | .578 | .046 | .093 | .489 | .668 |
D70 | .595 | .045 | .042 | .506 | .683 |
D80 | .600 | .045 | .032 | .512 | .688 |
D90 | .609 | .045 | .019 | .521 | .697 |
D98 | .627 | .044 | .006 | .540 | .714 |
VS | |||||
VS10 | .547 | .046 | .318 | .456 | .637 |
VS20 | .564 | .046 | .170 | .474 | .654 |
VS30 | .557 | .046 | .218 | .468 | .647 |
VS40 | .569 | .046 | .140 | .479 | .658 |
VS45 | .556 | .046 | .233 | .466 | .646 |
VS50 | .623 | .044 | .008 | .536 | .710 |
VS55 | .637 | .044 | .003 | .550 | .723 |
VS60 | .655 | .044 | .001 | .569 | .740 |
VS65 | .684 | .043 | .000 | .600 | .768 |
VS70 | .672 | .043 | .000 | .588 | .757 |
Total thyroid volume | |||||
TTV | .676 | .043 | .000 | .592 | .760 |
V | |||||
V10 | .552 | .046 | .262 | .462 | .642 |
V20 | .564 | .046 | .170 | .474 | .654 |
V30 | .563 | .046 | .177 | .473 | .653 |
V40 | .562 | .046 | .182 | .473 | .652 |
V45 | .564 | .046 | .168 | .475 | .654 |
V50 | .630 | .044 | .005 | .543 | .717 |
V55 | .589 | .046 | .057 | .498 | .679 |
V60 | .565 | .046 | .166 | .474 | .655 |
V65 | .495 | .047 | .906 | .403 | .586 |
V70 | .470 | .046 | .519 | .379 | .561 |
Pearson correlation coefficients between strongest predictive variables_ P< 0_001 for all correlations
Dmin | TTV | VS65 | V50 | |
---|---|---|---|---|
1.000 | -.398 | -.537 | .842 | |
-.398 | 1.000 | .853 | -.331 | |
-.537 | .853 | 1.000 | -.462 | |
.842 | -.331 | -.462 | 1.000 |
The incidence of hypothyroidism in the study population
Time (months) | N (%) |
---|---|
6 | 21 (13.5) |
12 | 37 (23.7) |
18 | 48 (30.8) |
24 | 59 (37.8) |
30 | 66 (42.3) |
36 | 70 (44.9) |
42 | 70 (44.9) |